Hinova Pharmaceuticals Inc. Share Price
Equities
688302
CNE1000059F5
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.25 CNY | +2.09% | +0.50% | -41.91% |
26/04 | Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/04 | China Stocks Fall Ahead of March Economic Data Release | MT |
Sales 2024 * | 130M 17.95M 1.5B | Sales 2025 * | 487M 67.25M 5.61B | Capitalization | 3B 414M 34.5B |
---|---|---|---|---|---|
Net income 2024 * | -472M -65.18M -5.44B | Net income 2025 * | -124M -17.12M -1.43B | EV / Sales 2024 * | 23 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 6.15 x |
P/E ratio 2024 * |
-6.34
x | P/E ratio 2025 * |
-24.3
x | Employees | 181 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
1 day | +2.09% | ||
1 week | +0.50% | ||
1 month | +4.02% | ||
3 months | -18.22% | ||
6 months | -37.46% | ||
Current year | -41.91% |
Managers | Title | Age | Since |
---|---|---|---|
Xing Hai Li
FOU | Founder | 61 | 05/13/05 |
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 05/13/05 |
Ze Yan Shi
DFI | Director of Finance/CFO | 43 | 12/21/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 05/13/05 |
Xing Hai Li
FOU | Founder | 61 | 05/13/05 |
Yuan Lun Chen
BRD | Director/Board Member | 54 | 21/20/21 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 30.25 | +2.09% | 738,135 |
30/24/30 | 29.63 | -0.67% | 309,747 |
29/24/29 | 29.83 | +0.44% | 610,530 |
28/24/28 | 29.7 | -0.67% | 925,621 |
27/24/27 | 29.9 | -0.66% | 695,057 |
End-of-day quote Shanghai S.E., May 31, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.91% | 414M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- 688302 Stock